The univariate regression analysis of non-survival at day 28 post-infusion of CP found no association with sex, ABO blood type, COPD/asthma, obesity, hypertension, or diabetes (Table 2). Here, CP is linked to obesity due to melanocortin 4 receptor deficiency.